Cartesian Therapeutics (RNAC) Appoints Kemal Malik to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. BROS
5. FIS
6. QCOM
7. DDOG
8. EW
9. ZG
10. W

Go back to Cartesian Therapeutics (RNAC) Appoints Kemal Malik to its Board

Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

July 2, 2024 4:05 PM EDT

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced the appointment of Kemal Malik, MBBS to its Board of Directors. Dr. Malik brings to Cartesian over 30 years of global development, regulatory, and commercial expertise at leading pharmaceutical organizations.

"We are thrilled to welcome Dr. Malik, a proven leader and industry veteran, to our Board of Directors, said Carsten Brunn, Ph.D., President and Chief Executive Officer of Cartesian. His deep experience in successfully... More